Drug Shortage Report for ZINECARD
Report ID | 2050 |
Drug Identification Number | 02153440 |
Brand name | ZINECARD |
Common or Proper name | ZINECARD |
Company Name | PFIZER CANADA ULC |
Market Status | DORMANT |
Active Ingredient(s) | DEXRAZOXANE |
Strength(s) | 500MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 1 EACH / CHAQUE |
ATC code | V03AF |
ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2016-12-15 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2020-03-03 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2020-03-03 | French | Compare |
v9 | 2020-03-03 | English | Compare |
v8 | 2018-03-07 | French | Compare |
v7 | 2018-03-07 | English | Compare |
v6 | 2018-02-28 | French | Compare |
v5 | 2018-02-28 | English | Compare |
v4 | 2017-05-11 | French | Compare |
v3 | 2017-05-11 | English | Compare |
v2 | 2017-03-13 | French | Compare |
v1 | 2017-03-13 | English | Compare |
Showing 1 to 10 of 10